Aqua Bio Technology
ISIN: NO0010307135 | Ticker: ABT
Aqua Bio Technology is well into the third phase of its development, providing natural and sustainable ingredients to the cosmetics industry and skincare products and consumers.
ABT developed and commercialized its proprietary enzyme technology based on the salmon’s hatching fluid. The ingredient Aquabeautine XL™ holds several properties attractive to skincare product manufacturers. The technology has since 2012 been licensed to a U.S. based skincare company.
The second step in developing ABT was establishing the Company as a center for commercialization of third party biotechnology. ABT has collaborated with several technology owners since 2012 and is developing and commercializing natural and sustainable skincare ingredients based on e.g. algae and olives for the industry.
2000
Served areaWorldwide
HeadquartersFornebuveien 37, 1366 Lysaker – Norway
20,673,792
IPOJan. 1, 2000
Stock exchange(s)Euronext Oslo